skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Mostrar Somente
Refinado por: Base de dados/Biblioteca: EBSCOhost Academic Search Premier remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A 5-Drug Regimen Maximizing the Dose of Cyclophosphamide is Effective Therapy for Adult Burkitt or Burkitt-like Lymphomas
A 5-Drug Regimen Maximizing the Dose of Cyclophosphamide is Effective Therapy for Adult Burkitt or Burkitt-like Lymphomas
Material Type:
Artigo 		Adicionar ao Meu Espaço

A 5-Drug Regimen Maximizing the Dose of Cyclophosphamide is Effective Therapy for Adult Burkitt or Burkitt-like Lymphomas

Kujawski, Lisa A. ; Longo, Walter L. ; Williams, Eliot C. ; Turman, Nancy J. ; Brandt, Nancy ; Mosher, Deane F. ; Eickhoff, Jens C. ; Kahl, Brad S.

Cancer investigation, 2007-01, Vol.25 (2), p.87-93 [Periódico revisado por pares]

England: Informa UK Ltd

Texto completo disponível

Citações Citado por
2
Aberrant cytokine signaling in leukemia
Aberrant cytokine signaling in leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Aberrant cytokine signaling in leukemia

Van Etten, R A

Oncogene, 2007-10, Vol.26 (47), p.6738-6749 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells
Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells

Pardanani, A ; Lasho, T ; Chen, D ; Kimlinger, T K ; Finke, C ; Zblewski, D ; Patnaik, M M ; Reichard, K K ; Rowinsky, E ; Hanson, C A ; Brooks, C ; Tefferi, A

Leukemia, 2015-07, Vol.29 (7), p.1605-1608 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
ABO, alemtuzumab and allogeneic transplantation
ABO, alemtuzumab and allogeneic transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

ABO, alemtuzumab and allogeneic transplantation

Cooling, L

Bone marrow transplantation (Basingstoke), 2015-07, Vol.50 (7), p.881-883 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
ABO, alemtuzumab and allogeneic transplantation: this article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue
ABO, alemtuzumab and allogeneic transplantation: this article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue
Material Type:
Artigo 		Adicionar ao Meu Espaço

ABO, alemtuzumab and allogeneic transplantation: this article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue

Cooling, L

Bone marrow transplantation (Basingstoke), 2015-07, Vol.50 (7), p.881 [Periódico revisado por pares]

Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse
Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse
Material Type:
Artigo 		Adicionar ao Meu Espaço

Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse

Boddu, P ; Jorgensen, J ; Kantarjian, H ; Borthakur, G ; Kadia, T ; Daver, N ; Alvarado, Y ; Pemmaraju, N ; Bose, P ; Naqvi, K ; Yilmaz, M ; Pierce, S ; Brandt, M ; DiNardo, C D ; Jabbour, E J ; Konopleva, M ; Garcia-Manero, G ; Cortes, J ; Ravandi, F

Leukemia, 2018-01, Vol.32 (1), p.241-244 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Activation of the NF- B pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKK
Activation of the NF- B pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKK
Material Type:
Artigo 		Adicionar ao Meu Espaço

Activation of the NF- B pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKK

Malinge, S ; Monni, R ; Bernard, O ; Penard-Lacronique, V

Oncogene, 2006-06, Vol.25 (25), p.3589-3597 [Periódico revisado por pares]

New York: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Activation of the NF-κB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKα
Activation of the NF-κB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKα
Material Type:
Artigo 		Adicionar ao Meu Espaço

Activation of the NF-κB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKα

MALINGE, S ; MONNI, R ; BERNARD, O ; PENARD-LACRONIQUE, V

Oncogene, 2006-06, Vol.25 (25), p.3589-3597 [Periódico revisado por pares]

Basingstoke: Nature Publishing

Texto completo disponível

Citações Citado por
9
Acute Myeloid Leukemia Genetics: Risk Stratification and Implications for Therapy
Acute Myeloid Leukemia Genetics: Risk Stratification and Implications for Therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Acute Myeloid Leukemia Genetics: Risk Stratification and Implications for Therapy

Wang, Michael L ; Bailey, Nathanael G

Archives of pathology & laboratory medicine (1976), 2015-10, Vol.139 (10), p.1215-1223 [Periódico revisado por pares]

United States: College of American Pathologists

Texto completo disponível

Citações Citado por
10
Acute myeloid leukemia-targeted toxin activates both apoptotic and necroptotic death mechanisms
Acute myeloid leukemia-targeted toxin activates both apoptotic and necroptotic death mechanisms
Material Type:
Artigo 		Adicionar ao Meu Espaço

Acute myeloid leukemia-targeted toxin activates both apoptotic and necroptotic death mechanisms

Horita, Henrick ; Frankel, Arthur E ; Thorburn, Andrew Najbauer, Joseph

PloS one, 2008-12, Vol.3 (12), p.e3909-e3909 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (652)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (655)
  2. Reports  (4)
  3. magazinearticle  (3)
  4. Resenhas  (2)
  5. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1998  (6)
  2. 1998Até2003  (52)
  3. 2004Até2009  (168)
  4. 2010Até2016  (258)
  5. Após 2016  (181)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (661)
  2. Japonês  (80)
  3. Espanhol  (3)
  4. Português  (2)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.